Sponsor:
Boston Children's Hospital
Code:
NCT05455359
Conditions
Esophageal Motility Disorders
Gastric Motor Dysfunction
Aspiration Pneumonia
Gastro Esophageal Reflux
Eligibility Criteria
Sex: All
Age: 5 - 21
Healthy Volunteers: Not accepted
Interventions
Prucalopride
Famotidine
Brief summary:
Conditions
Esophageal Motility Disorders
Gastric Motor Dysfunction
Aspiration Pneumonia
Gastro Esophageal Reflux
Study ID
NCT05455359
Start date
Feb 13, 2025
Status verified date
Jul, 2026
Completion date
May 31, 2027
Anticipated
Primary completion date
May 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 5 - 21
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: Arm 1
experimental: Arm 2
Interventions
Prucalopride
Famotidine
Primary outcome measure
Central contacts
Locations
Boston Children's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Sponsor
Boston Children's Hospital
Last update posted
Aug 3, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2026-08-03.